Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.11, 2010-11, pp. : 1041-1054

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cinacalcet hydrochloride for the treatment of hyperparathyroidism

By Verheyen Nicolas Pilz Stefan Eller Kathrin Kienreich Katharina Fahrleitner-Pammer Astrid Pieske Burkert Ritz Eberhard Tomaschitz Andreas

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 793-806

Informa Healthcare

Access to resources Recommend Favorite

Early treatment with cinacalcet is more cost effective than delayed treatment for patients with hyperparathyroidism secondary to renal failure

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 529, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan

By Iseki Kunitoshi

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 601-610

Informa Healthcare

Access to resources Recommend Favorite

Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism

By Franceschini Nora Joy Melanie S Kshirsagar Abhijit

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1413-1421

Informa Healthcare

Access to resources Recommend Favorite

Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis

By Fiedler Roman

Clinical Drug Investigation, Vol. 27, Iss. 12, 2007-01 ,pp. : 865-866

Adis International

Access to resources Recommend Favorite